<DOC>
	<DOC>NCT00293696</DOC>
	<brief_summary>To evaluate anti-androgen (bicalutamide) induced biological and molecular changes in prostate comparison to chemical castration induced (goserelin) ones</brief_summary>
	<brief_title>Casodex/Zoladex Biomarkers in Localised Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<mesh_term>Bicalutamide</mesh_term>
	<criteria>1. Histologically confirmed localised prostate biopsy specimen that contains sufficient tumour for evaluation of cell proliferation and apoptosis markers 2. Patients who are scheduled for radical prostatectomy with curative intents</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>biomarker study</keyword>
	<keyword>Patients with clinically localised prostate cancer</keyword>
</DOC>